Bristol-Myers Squibb Co (BMY)
49.40
+0.38
(+0.78%)
USD |
NYSE |
Sep 20, 16:00
49.43
+0.03
(+0.06%)
After-Hours: 20:00
Bristol-Myers Squibb Cash from Operations (TTM): 14.16B for June 30, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 14.16B |
March 31, 2024 | 13.72B |
December 31, 2023 | 13.86B |
September 30, 2023 | 12.91B |
June 30, 2023 | 11.85B |
March 31, 2023 | 12.22B |
December 31, 2022 | 13.07B |
September 30, 2022 | 13.82B |
June 30, 2022 | 15.40B |
March 31, 2022 | 16.20B |
December 31, 2021 | 16.21B |
September 30, 2021 | 15.50B |
June 30, 2021 | 12.51B |
March 31, 2021 | 13.94B |
December 31, 2020 | 14.05B |
September 30, 2020 | 12.88B |
June 30, 2020 | 13.17B |
March 31, 2020 | 10.76B |
December 31, 2019 | 8.21B |
September 30, 2019 | 9.584B |
June 30, 2019 | 8.307B |
March 31, 2019 | 7.281B |
December 31, 2018 | 7.066B |
September 30, 2018 | 4.628B |
June 30, 2018 | 5.062B |
Date | Value |
---|---|
March 31, 2018 | 5.589B |
December 31, 2017 | 5.275B |
September 30, 2017 | 5.601B |
June 30, 2017 | 5.292B |
March 31, 2017 | 4.147B |
December 31, 2016 | 3.058B |
September 30, 2016 | 2.499B |
June 30, 2016 | 1.619B |
March 31, 2016 | 1.251B |
December 31, 2015 | 2.105B |
September 30, 2015 | 1.793B |
June 30, 2015 | 2.172B |
March 31, 2015 | 3.157B |
December 31, 2014 | 3.148B |
September 30, 2014 | 3.986B |
June 30, 2014 | 4.136B |
March 31, 2014 | 4.59B |
December 31, 2013 | 3.545B |
September 30, 2013 | 2.971B |
June 30, 2013 | 6.502B |
March 31, 2013 | 6.126B |
December 31, 2012 | 6.941B |
September 30, 2012 | 7.673B |
June 30, 2012 | 4.787B |
March 31, 2012 | 4.746B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
8.21B
Minimum
Dec 2019
16.21B
Maximum
Dec 2021
13.20B
Average
13.45B
Median
Cash from Operations (TTM) Benchmarks
Amgen Inc | 6.446B |
Johnson & Johnson | 24.64B |
Eli Lilly and Co | 4.510B |
Merck & Co Inc | 16.69B |
Pfizer Inc | 8.005B |